{
    "10.1002/adhm.201800296.pdf": {
        "new materials": {
            "Yes/No": "Yes",
            "sentence": " The article mentions the development of ZnDPA-conjugated Fe"
        },
        "screening algorithms": {
            "Yes/No": "No",
            "sentence": " The paper does not mention any specific screening algorithms, but it discusses the development of an apoptosis-homing nanoplatform for tumor theranostics, which implies a method or approach to identify individuals with certain conditions or traits."
        },
        "AI algorithms": {
            "Yes/No": "Yes",
            "sentence": " The apoptosis-homing nanoplatform based on zinc(II) dipicolylamine (ZnDPA) conjugated Fe"
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " The mice were divided into eight groups randomly.\n\nThe models mentioned in the article are:\n\n* Apoptotic I (4T1 tumor-bearing mice induced by DOX)\n* Apoptotic II (4T1 tumor-bearing mice induced by DOX twice for 3 d)\n* Normal group (4T1 tumor-bearing mice without treatment of DOX)\n\nThese groups are used to evaluate the amplifying apoptosis-targeted property of MNPs"
        },
        "funding": {
            "Yes/No": "No",
            "sentence": " There is no indication in this document that mentions who funded the research. The text only provides information about the study itself, its methods, and results, but does not include any information on funding sources or sponsors."
        },
        "material datasets": {
            "Yes/No": "No",
            "sentence": " The article does not mention sharing any AI or material-related datasets, as there is no mention of such sharing in the provided text."
        },
        "drug formulations explored": {
            "Yes/No": "No",
            "sentence": " The article has successfully developed ZnDPA-conjugated Fe@Fe3O4 NPs by strain-promoted click chemistry, which could be rendered as a nanotheranostic agent for enhanced photothermal therapy in vivo."
        },
        "novel drug formulations": {
            "Yes/No": "No",
            "sentence": " The article does not specifically identify any novel drug formulations, but rather reports on the development of ZnDPA-conjugated Fe@Fe3O4 NPs for enhancing MRI and photothermal therapy in cancer treatment."
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "No",
            "sentence": " According to the provided context, there is no mention of lead small-molecule drug candidates. The article primarily focuses on the development and characterization of Fe@Fe3O4 nanoparticles conjugated with ZnDPA for targeted photothermal therapy and imaging of apoptotic cancer cells."
        },
        "clinical trials": {
            "Yes/No": "No",
            "sentence": " There is no mention of clinical trials in the article; it appears to be a research study focused on developing and evaluating an apoptosis-homing nanoplatform for tumor theranostics."
        }
    },
    "10.1002_adhm.201800296.pdf": {
        "new materials": {
            "Yes/No": "No",
            "sentence": " The amplifying apoptosis-targeted T -weighted MR imaging in vivo of MNPs"
        },
        "screening algorithms": {
            "Yes/No": "No",
            "sentence": " The researchers were able to enhance the accumulation value of MNPs"
        },
        "experimental methodology": {
            "Yes/No": "Based on the provided text, here are the answers:\n\n**New or novel experimental methodology used?**\n\n* No",
            "sentence": " The document does not mention any new or novel experimental methodology used.\n\nThe document seems to be a research article in the field of biomedical science, focusing on the application of magnetic nanoparticles (MNPs) and fluorescent tags for targeted accumulation and amplification of apoptosis imaging. While it discusses various methods such as confocal laser scanning microscopy, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) staining, and MRI imaging, there is no mention of novel experimental methodologies.\n\n**Screening algorithms used in the document?**\n\n* No "
        },
        "ML algorithms": {
            "Yes/No": "No",
            "sentence": " The tumor-homing ability of nanomaterials plays a key role in achieving their cancer precision theranostics."
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " We developed an apoptosis-homing nanoplatform based on zinc(II) dipicolylamine (ZnDPA) conjugated Fe"
        },
        "funding": {
            "Yes/No": "Yes",
            "sentence": " \"The authors thank the National Natural Science Foundation of China (Nos. 81772796, 81903153), the Fundamental Research Funds for the Central Universities (No. 2019kfyXJQD-045) and the Program of Introducing Talents in Guangdong Province (No. 2017GC0015).\""
        },
        "material datasets": {
            "Yes/No": "Yes",
            "sentence": " The degree of apoptosis on the different tumor models was further confirmed by fluorescent TUNEL staining (Figure S7, Supporting Information)."
        },
        "drug formulations explored": {
            "Yes/No": "Yes",
            "sentence": " The degree of apoptosis on the different tumor models was further confirmed by fluorescent TUNEL staining (Figure S7, Supporting Information)."
        },
        "novel drug formulations": {
            "Yes/No": "Yes",
            "sentence": " A novel formulation of MNPs"
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "Yes",
            "sentence": " The amplifying apoptosis-targeted T-weighted MR imaging in vivo of MNPs"
        },
        "clinical trials": {
            "Yes/No": "Yes",
            "sentence": " There is no specific mention of \"clinical trials\" in the provided text, but it mentions an \"apoptotic xenograft model constructed by doxorubicin\", which could be related to pre-clinical trial studies. "
        }
    },
    "10.1007_s12598-020-01402-8.pdf": {
        "new materials": {
            "Yes/No": "Yes",
            "sentence": " The emphasis of the new Rec. 2020 ultra-high-definition television (UHDTV) standard is not on resolution but on color reproduction, which relies on the following primary colors: 630 nm for red, 532 nm for green, 467 nm for blue, and..."
        },
        "screening algorithms": {
            "Yes/No": "No",
            "sentence": " The authors also evaluated the color stability under changing temperatures, power and applied potential... \n\n(This sentence implies a measurement of some kind, but it doesn't mention a new or novel high-throughput screening algorithm. It's more about evaluating existing properties of the material rather than discovering new ones through a large-scale screen.)"
        },
        "experimental methodology": {
            "Yes/No": "Yes",
            "sentence": " The authors investigated the oxidation pathway of Sn-based perovskite film and determined that the formation of SnI was the crucial step. With this knowledge, preventing the formation of SnI was proposed as an effective strategy to retard the oxidation of Sn.\n\nThe document mentions a novel solution (HPA as a mild reducing agent) but not a completely new or novel experimental methodology used in the context of the question."
        },
        "ML algorithms": {
            "Yes/No": "No",
            "sentence": " The emphasis of the new Rec.2020 ultra-high-definition television (UHDTV) standard is not on resolution but on color reproduction. \n\nThere are no sentences in the provided text mentioning the development of a machine learning or deep learning algorithm, AI model, or architecture."
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " The authors chose the Sn-based perovskites with natural quantum well structure as active layers for light emission."
        },
        "funding": {
            "Yes/No": "Yes",
            "sentence": " RareMet. https:"
        },
        "material datasets": {
            "Yes/No": "No",
            "sentence": " None of the sentences provided in the examples describe the development of new material-related datasets or databases, and neither does the given text."
        },
        "drug formulations explored": {
            "Yes/No": "No",
            "sentence": " Despite excellent external quantum efficiencies (EQE) and brightness of QD-based or lead halide perovskite light-emitting diodes, their color purities cannot meet the luminanceof70 cd(cid:2)m-2under5.8 VwithanEQEof0.3%"
        },
        "novel drug formulations": {
            "Yes/No": "No",
            "sentence": " This work introduces HPA as a viable solution to the oxidation issues of Sn-based perovskite."
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "No",
            "sentence": " The authors also evaluated the color stability under changing temperatures, power and applied potential, finding that the emission shift was <3 nm at low temperature and high power, and less than 0.3 nm(V-1) at working voltage (Fig. 1c)."
        },
        "clinical trials": {
            "Yes/No": "No",
            "sentence": " The authors chose the Sn-based perovskites with natural quantum well structure as active layers for light emission. \n\nThere is no mention of clinical trials in the provided text, only discussions about research on materials and devices for ultra-high-definition television displays."
        }
    },
    "10.1039_c8sc04808h.pdf": {
        "new materials": {
            "Yes/No": "No",
            "sentence": " The unexpected presence of Ni(II)-thienyl iodide a\ue09der polymerizing XMg-Th-Cl or XMg-Th-Br (I"
        },
        "screening algorithms": {
            "Yes/No": "No",
            "sentence": " The KCTP catalytic cycle involves four steps: transmetalation, reductive elimination, ring walking, and oxidative addition (Scheme 1)."
        },
        "experimental methodology": {
            "Yes/No": "No",
            "sentence": " The document does not mention any new or novel experimental methodology used.\n\nNo "
        },
        "ML algorithms": {
            "Yes/No": "No",
            "sentence": " We here therefore introduce ionbot, a novel open modification search engine that is the first to fully merge machine learning with peptide identification."
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " The catalysts used were novel 3D porous polymers synthesized via the sol-gel process, which was first time employed for this application."
        },
        "funding": {
            "Yes/No": "Yes",
            "sentence": " None of these references have an acknowledgement section mentioning funding, award or financial support."
        },
        "material datasets": {
            "Yes/No": "No",
            "sentence": " The unexpected presence of Ni(II)-thienyl iodide after polymerizing XMg-Th-Cl or XMg-Th-Br (I"
        },
        "drug formulations explored": {
            "Yes/No": "Yes",
            "sentence": " The catalyst rests as dissociated Ni(phosphine) complex and Ni(II)-dithienylcomplex2 in the polymerization of XMg-Th-Cl."
        },
        "novel drug formulations": {
            "Yes/No": "Yes",
            "sentence": " The observed singlet does not match any intermediates in the catalytic cycle (complex 1\u20134 in Scheme 1) suggesting that some of the active catalyst is diffusing away from the propagating polymer chain, likely due to the difficult OA or other side reactions.7a,17 This is consistent with a mixture of polymers with different end-group compositions being observed in this polymerization(Fig.S9,ESI\u2020).15b,19"
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "Yes",
            "sentence": " In polymer chemistry, cross coupling reactions are particularly important for the synthesis of p-conjugated polymers."
        },
        "clinical trials": {
            "Yes/No": "Yes",
            "sentence": " The percent buried volume (%V ) around the Ni centre in complex 1 increases moving from Cl to Br to I (Fig. S10, ESI\u2020).21 Alter- natively, weaker Mg\u2013I interactions serve to further increase the AE for I (so\ue09d base) compared to Br and Cl."
        }
    }
}